FDA says Pfizer’s new RSV vaccine for older adults may trigger painful and potentially deadly Guillain-Barre syndrome in one in 10,000 patients
‘Pfizer’s new RSV vaccine for older adults may trigger the potentially deadly Guillain-Barre syndrome, the Food and Drug Administration (FDA) has warned.
In clinical trials, two participants in their 60s developed the condition that can also cause crippling pain, muscle weakness and paralysis.
One of the patients recovered after three months, but the second took six months to return to normal. They were among 20,000 adults who got the experimental shot.’
Trending:
- Michael Burry Scatter Chart of the Coming Bank Failures
- We Are in the Eye of the Hurricane – What Happens Next?
- Here is a detailed list of privacy oriented Search Engines I’ve found that won’t leave information conveniently under the rug
- WSJ: Two Hundred Banks At Risk Of Bankruptcy
- Scientists sound the alarm as plastic waste forms rocks off coast of Brazil
- Cop car decides its had enough. Just runs over a bunch of people standing in its way…
- If Trump Is Arrested Next Week, He Will Win Re-Election in a Landslide
- 6th-grader is sentenced to 1-day-hard-labor for refusing to listen to CNN’s lies and propaganda.
- Stand Up Comedy Clip “Chinese Spy Balloon” by comedian Jim Breuer
- OPRAH STANDS TO LOSE $590 MILLION AFTER COLLAPSE OF SVB
Views: 68